SEC Form 5 · accession 0001185185-18-000095
INVO Bioscience, Inc. · IVOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kathleen t Karloff
Officer — CEO / Chairman · Director
Period of report
Dec 27, 2017
Accepted (ET)
Jan 23, 2018 · 4:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001417926
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock Restricted | Dec 27, 2017 | S | 100,000 | $0.15 | D | 11,960,000 | D |
Table II — derivative securities
No Table II lines on this filing.